Cluster: Health Economy

Does infant formula have too many ingredients?

This content was published on Feb 26, 2026 Several European countries, including in Switzerland, have reported illnesses that may be linked to toxic contamination in infant formula.

There have been reports of hospitalisation of infants who were fed the recalled formula in France and Spain.

Food safety

Infant formula recall: Is trying to copy breastmilk increasing risk of contamination?

This content was published on Feb 25, 2026 A contaminated additive found naturally in breastmilk is responsible for the recent recall of infant formula worldwide.

The banking sector has been particularly affected by redundancies.

Pharma supply chains

Why unemployment in Switzerland is increasing more than elsewhere in Europe

This content was published on Feb 24, 2026 The number of people in Switzerland who are out of work increased for the second year in a row. This contrasts with the situation in the European Union.

Detail view of a thousand Swiss franc note

Assisted suicide

Switzerland no longer wants to foot the bill for ‘suicide tourism’

This content was published on Feb 21, 2026 In Switzerland, all deaths through assisted suicide must be followed by a medical and legal investigation. This entails considerable costs for the state.

Roche obtains FDA approval to treat a form of leukaemia

New treatments

FDA approves Roche leukaemia treatment

This content was published on Feb 20, 2026 Genentech obtains FDA approval for treatment for chronic lymphocytic leukaemia (CLL).

Production of cigarettes at a factory in Switzerland

Prevention

Links between universities and tobacco industry a threat to Swiss research, NGO warns

This content was published on Feb 19, 2026 An investigation by the Transparency and Truth initiative of the NGO OxySuisse reveals links between the tobacco industry and several Swiss universities.

Top-selling drugs discounted to lower premiums

Drug pricing

Switzerland mulls discounts on top-selling drugs to cut health costs

This content was published on Feb 19, 2026 The Swiss government has opened a consultation on limiting the steady rise of healthcare costs by granting discounts on best-selling medicines in the country.

Ketamine consumption is on the rise in Switzerland

Health systems

Swiss wastewater analysis shows increase in ketamine, crack cocaine use

This content was published on Feb 19, 2026 More use of ketamine and crack cocaine, but slightly less of cannabis and crystal meth: these are the results of analyses of Swiss wastewater published on Thursday.

The Federal Council sets the course for agricultural policy 2030+.

Agribusiness

Swiss government announces measures for future food security

This content was published on Feb 19, 2026 The federal government has set out the broad lines of the future agricultural policy, to be in force from 2030.

Trump in White House. Pharma leaders behind him.

Drug pricing

The art of the deal: what are Trump’s pharma announcements really worth?

This content was published on Feb 18, 2026 Big Pharma announced a series of groundbreaking agreements with the White House in 2025. But how much of it is just for show?

Page 6 of 34

First … 4 5 6 7 8 … Last

Cluster: Health Economy

Popular Stories

Most Discussed